FOR US EYE CARE PROFESSIONALS
IMPORTANT SAFETY INFORMATION FULL PRESCRIBING INFORMATION PATIENT INFORMATION MEDICAL INFORMATION PATIENT SITEIndication
Xiidra® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of signs and symptoms of dry eye disease (DED).
Important Safety Information
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for Full Prescribing Information.
References
References
References
References
References
References
References
References
Reference
References
References
References
References
Reference
References
Reference
Reference
Reference
References
References
References
Indication
Xiidra® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of signs and symptoms of dry eye disease (DED).
Important Safety Information
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for Full Prescribing Information.